1.05 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
MIRA Pharmaceuticals, Inc. Common Stock
MIRANASDAQ • USD
1.04
↘ 0.01 (0.86%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
1.04
↘ 0.01 (0.86%)
Market: CLOSED
Open?$1.04
High?$1.07
Low?$1.02
Prev. Close?$1.05
Volume?126.5K
Avg. Volume?174.9K
VWAP?$1.04
Rel. Volume?0.72x
Bid / Ask
Bid?$1.02 × 8.1K
Ask?$1.08 × 3.8K
Spread?$0.06
Midpoint?$1.05
Valuation & Ratios
Market Cap?44.1M
Shares Out?42.0M
Float?32.2M
Float %?76.8%
P/E Ratio?N/A
P/B Ratio?4.25
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.75Strong
Quick Ratio?15.75Strong
Cash Ratio?9.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?4.25FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-307.9%WEAK▾
ROA?-288.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$37.8M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Employees
2
Market Cap
44.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-08-03
Address
1200 BRICKELL AVENUE
MIAMI, FL 33131
Phone: 813-369-5150
MIAMI, FL 33131
Phone: 813-369-5150